In a separate study involving 49 SLE patients and 40 healthy controls, IL-36α mRNA was significantly higher in SLE patients, with fold changes indicating increased expressions in those with moderate to high disease activity (SLEDAI >5) compared with those with mild activity (SLEDAI ≤5) (109). Here, IL36A is linked to systemic lupus erythematosus.